FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+3.21%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$22.2B
AUM Growth
+$19M
(+0.09%)
Cap. Flow
-$219M
Cap. Flow
% of AUM
-0.98%
Top 10 Holdings %
Top 10 Hldgs %
27.05%
Holding
698
New
75
Increased
150
Reduced
234
Closed
204
Top Buys
| 1 |
PPG Industries
PPG
|
$202M |
| 2 |
Cigna
CI
|
$183M |
| 3 |
Bristol-Myers Squibb
BMY
|
$182M |
| 4 |
Amazon
AMZN
|
$180M |
| 5 |
AB InBev
BUD
|
$134M |
Top Sells
| 1 |
Hilton Worldwide
HLT
|
$142M |
| 2 |
AGN
Allergan plc
AGN
|
$115M |
| 3 |
Nike
NKE
|
$102M |
| 4 |
Micron Technology
MU
|
$97.8M |
| 5 |
Toll Brothers
TOL
|
$95.1M |
Sector Composition
| 1 | Healthcare | 23.63% |
| 2 | Technology | 17.55% |
| 3 | Consumer Discretionary | 11.93% |
| 4 | Financials | 11.1% |
| 5 | Communication Services | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
POT
426
DELISTED
Potash Corp Of Saskatchewan
POT
| $850K | ﹤0.01% |
27,450
| – | – |
|
427
Waste Management
WM
$88.6B
| $819K | ﹤0.01% |
17,675
-1,565
| -8% | -$72.5K |
|
|
CVA
428
DELISTED
Covanta Holding Corporation
CVA
| $798K | ﹤0.01% |
37,680
| – | – |
|
|
NVTA
429
DELISTED
Invitae Corporation
NVTA
| $780K | ﹤0.01% |
+52,400
| New | +$780K |
|
|
ONCE
430
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $774K | ﹤0.01% |
12,850
+3,350
| +35% | +$202K |
|
431
Lincoln National
LNC
$7.98B
| $767K | ﹤0.01% |
12,950
| – | – |
|
432
Arcturus Therapeutics
ARCT
$485M
| $760K | ﹤0.01% |
+16,600
| New | +$760K |
|
433
Ocular Therapeutix
OCUL
$2.37B
| $743K | ﹤0.01% |
35,307
+5,650
| +19% | +$119K |
|
|
PX
434
DELISTED
Praxair Inc
PX
| $732K | ﹤0.01% |
6,125
| – | – |
|
435
SAP
SAP
$313B
| $725K | ﹤0.01% |
10,330
-246,312
| -96% | -$17.3M |
|
436
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $723K | ﹤0.01% |
+25,000
| New | +$723K |
|
|
DERM
437
DELISTED
Dermira, Inc.
DERM
| $702K | ﹤0.01% |
40,000
| – | – |
|
438
Vericel Corp
VCEL
$1.72B
| $700K | ﹤0.01% |
196,093
| – | – |
|
|
ITC
439
DELISTED
ITC HOLDINGS CORP
ITC
| $700K | ﹤0.01% |
21,765
| – | – |
|
440
Revvity
RVTY
$10.1B
| $679K | ﹤0.01% |
12,900
-12,900
| -50% | -$679K |
|
441
Cardiff Oncology
CRDF
$144M
| $671K | ﹤0.01% |
+918
| New | +$671K |
|
|
AAC
442
DELISTED
AAC Holdings, Inc.
AAC
| $658K | ﹤0.01% |
+15,100
| New | +$658K |
|
443
Duke Energy
DUK
$93.8B
| $636K | ﹤0.01% |
9,010
| – | – |
|
444
Norfolk Southern
NSC
$62.3B
| $631K | ﹤0.01% |
7,225
| – | – |
|
445
Clean Harbors
CLH
$12.7B
| $620K | ﹤0.01% |
11,545
+1,055
| +10% | +$56.7K |
|
446
Credicorp
BAP
$20.7B
| $614K | ﹤0.01% |
4,422
-9,188
| -68% | -$1.28M |
|
|
RDHL
447
Redhill Biopharma
RDHL
$3.29M
| $610K | ﹤0.01% |
+35
| New | +$610K |
|
448
Merck
MRK
$212B
| $609K | ﹤0.01% |
11,219
| – | – |
|
|
XNPT
449
DELISTED
XENOPORT, INC.
XNPT
| $606K | ﹤0.01% |
+98,850
| New | +$606K |
|
450
Itaú Unibanco
ITUB
$76.6B
| $579K | ﹤0.01% |
128,009
+34,062
| +36% | +$154K |
|